CLNN
Clene (CLNN)
$
40About Clene (CLNN)
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Details
Daily high
$4.51
Daily low
$4.23
Price at open
$4.23
52 Week High
$11.00
52 Week Low
$3.82
Market cap
35.1M
Dividend yield
0.00%
Volume
69,658
Avg. volume
116,346
P/E ratio
-15.76
Clene News
Details
Daily high
$4.51
Daily low
$4.23
Price at open
$4.23
52 Week High
$11.00
52 Week Low
$3.82
Market cap
35.1M
Dividend yield
0.00%
Volume
69,658
Avg. volume
116,346
P/E ratio
-15.76